China biotech Junshi Biosciences seeks up to $414 million in Hong Kong IPO

HONG KONG (Reuters) – Chinese biotech company Shanghai Junshi Biosciences is seeking up to $414 million in a Hong Kong initial public offering (IPO), making it the latest company to take advantage of …
( read original story …)

---